HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1162787Erstellt: 24. Oktober 2026
Formic Acid → 2-(2-(4-(2-(Methylamino)ethyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide
https://huagongshe.com/de/reaction/1162787
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Formic Acid | HCID 284 | — |
| Edukt | Methylamine | HCID 6329 | — |
| Edukt | 2-(1-(2-(3-carbamoyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-ylamino)-2-oxoethyl)-3-(trifluoromethyl)1H-pyrazol-4-yl)ethyl methanesulfonate | HCID 59520461 | — |
| Lösungsmittel | Dimethylformamide | HCID 6228 | — |
| Produkt | 2-(2-(4-(2-(Methylamino)ethyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide | HCID 59520466 | 13,1% |
Reaktionsschritte
The 2-(1-(2-(3-carbamoyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-ylamino)-2-oxoethyl)-3-(trifluoromethyl)1H-pyrazol-4-yl)ethyl methanesulfonate (30 mg, 0.061 mmol) was dissolved in DMF (1 mL) and methylamine (2 M in THF, 1 mL, 2 mmol) added. The reaction mixture was heated at 120° C. for 5 min in the microwave. The THF was removed in vacuo and the reaction mixture filtered and purified by preparative reverse phase HPLC to give the formic acid salt of the desired product (3.6 mg, 0.008 mmol, 12%).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US07820707B2 |
|---|
| Quelldatensatz | uspto-grants-2010_10 |
|---|
| ORD ID | ord-4fcfae59353649e49cdea4ee85fd3982 |
|---|
| Quellennotiz | uspto-grants-2010_10 |
|---|